Candice Z. Ulmer, Ph.D.

Candice Ulmer

Dr. Candice Z. Ulmer, a native of South Carolina, graduated from the College of Charleston in 2012 with a B. S. in Chemistry and Biochemistry. While at the College of Charleston, Candice investigated the pharmaceutical photodegradation of NSAIDs using ESI-LC-MS/MS under the direction of Dr. Wendy Cory. Dr. Ulmer graduated (May 2016) with a PhD in Chemistry as a McKnight Doctoral Fellow from the University of Florida in Dr. Richard Yost’s research group. For her doctoral work, she applied UHPLC-HRMS techniques to profile the metabolome/lipidome of human cells and tissues to better understand the disease etiology of Type 1 Diabetes and melanoma skin cancer. Dr. Ulmer’s research comprised experience with various modes of ionization (e.g., MALDI, ESI, APCI, DESI, FlowProbe, and DART). She also incorporated novel stable isotope labeling methodologies such as Isotopic Ratio Outlier Analysis (IROA) to aid in the identification of metabolites as compound identification is still considered a bottleneck in metabolomics studies. In addition to her duties as a graduate student, she was an active researcher with the NIH-funded Southeast Center for Integrated Metabolomics (SECIM). Dr. Candice Ulmer was a NIST NRC Post-doctoral Research Associate (June 2016 – August 2017) and was involved with multi-omic UHPLC-HRMS method development, lipidomics interlaboratory studies, environmental exposure monitoring on human/marine life. Dr. Ulmer is currently a Clinical Chemist at the Centers for Disease Control and Prevention in Atlanta, GA. Her responsibilities as Project Lead and Acting Chief of the Clinical Reference Laboratory for Cancer, Kidney, and Bone Disease Biomarkers in the Clinical Chemistry Branch include the accurate measurement of chronic disease biomarkers (e.g., steroid and protein hormones) and the assessment of clinical analytical methods in patient care. Dr. Ulmer was nominated by the American Association of Clinical Chemistry (AACC) to serve on the newly-formed International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on Bone Metabolism. She is a co-chair of the American Society for Mass Spectrometry (ASMS) clinical chemistry interest group and publication committee, and assumes appointed/elected memberships in six committees for other scientific organizations that include the International Metabolomics Society, the Metabolomics Quality Assurance and Quality Control Consortium, Metabolomics of North America, and the American Chemical Society.

Dr. Ulmer is passionate about STEM outreach and minority representation. As a result, she serves on the ASMS Diversity Committee and is the co-founder of the Coalition of Black Mass Spectrometrists (CBM).

Scroll to Top